FindTrial
Sign In

comparison of efficacy of two medicines in treatment of scabies disease

A Comparative study of efficacy of Topical ivermectin and topical permethrin in treatment of scabies: a randomized control trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/07/035188
Enrollment
76
Registered
2021-07-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

Intervention1: IVERMECTIN: Ivermectin is a broad spectrum antiparasitic class of macrocyclic lactones known as avermectins. Control Intervention1: PERMETHRIN: PERMETHRIN IS A SCABICIDAL AGENT USED IN

Sponsors

ROHILKHAND MEDICAL COLLEGE AND HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who give consent for the study. Age group between 18-60 years. Patients willing for topical therapy with their consent. Patient of both the sexes. Mentally stable, oriented and coherent patients.

Exclusion criteria

Exclusion criteria: pregnant women were not included. Patients with serious systemic ailments Immunocompromised patients. Patients having other pruritic disorders.

Design outcomes

Primary

MeasureTime frame
RELIEF OF SYMPTOMS OF THE PATIENT.Timepoint: 1 WEEK, 2 WEEK , 3 WEEK, 4 WEEK—

Secondary

MeasureTime frame
TO LOOK FOR THE SIDE EFFECTS OF THE GIVEN DRUGSTimepoint: 1WEEK, 2 WEEK, 3 WEEK , 4 WEEK—

Countries

India

Contacts

Public ContactDR PRAVEEN KUMAR RATHORE

rohilkhand medical college

drpraveenderma@gmail.com9412332063

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026